Table 1.
Clinical characteristics of the 229 patients with chronic liver damage
| Characteristic | Chronic hepatitis | Liver cirrhosis | p value* |
|---|---|---|---|
| No. of patients | 124 | 105 | |
| Age (years) | 57 (24–78) | 64 (32–87) | p<0.001 |
| Gender (male/female) | 90/34 | 69/36 | ns |
| Etiology (HBV/HCV) | 30/94 | 21/84 | ns |
| No. with HCC | 7 (6%) | 49 (47%) | p<0.001 |
| No. with Hypertension | 15 (12%) | 21 (20%) | ns |
| BMI (kg/m2) | 22.4 (16.7–32.4) | 22.3 (14.5–32.2) | ns |
| T-Bil (mg/dl) | 0.8 (0.4–1.1) | 1.2 (0.4–2.6) | p<0.05 |
| AST (IU/l) | 49 (15–186) | 68 (14–346) | p<0.001 |
| ALT (IU/l) | 57 (7–274) | 56 (9–195) | ns |
| FBS (mg/dl) | 102 (72–225) | 92 (69–124) | p<0.01 |
| Alb (g/dl) | 4.1 (2.6–4.8) | 3.6 (2.3–4.7) | p<0.001 |
| PT (%) | 84 (55–100) | 70 (41–100) | ns |
| Plt (×104/µl) | 17.0 (5.0–34.2) | 11.8 (2.4–33.2) | p<0.001 |
Values are expressed as median (range).
*
by Mann-Whitney’s U test or Fischer’s exact probability test. Abbreviations used are; HBV, hepatitis B virus; HCV, hepatitis C virus; BMI, body mass index; HCC, hepatocellular carcinoma; T-Bil, total bilirubin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; FBS, fasting blood sugar; Alb, serum albumin; PT, prothrombin time; Plt, platelet count; ns, not significant.